Cargando…
Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma
Asthma is associated with increased levels of eosinophils in tissues, body fluids, and bone marrow. Elevated levels of eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP) have been noted in asthma patients. Higher levels of EDN and ECP are also associated with exacerbated asthm...
Autor principal: | Kim, Chang-Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564031/ https://www.ncbi.nlm.nih.gov/pubmed/23390439 http://dx.doi.org/10.3345/kjp.2013.56.1.8 |
Ejemplares similares
-
Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics
por: Lee, Youngsoo, et al.
Publicado: (2019) -
Montelukast Reduces Serum Levels of Eosinophil-Derived Neurotoxin in Preschool Asthma
por: Kim, Chang-Keun, et al.
Publicado: (2018) -
Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker
por: Rutten, Bert, et al.
Publicado: (2021) -
The Role of Eosinophil-Derived Neurotoxin and Vascular Endothelial Growth Factor in the Pathogenesis of Eosinophilic Asthma
por: Tota, Maciej, et al.
Publicado: (2023) -
Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)